61 related articles for article (PubMed ID: 22789836)
1. Cerebroside D, a glycoceramide compound, improves experimental colitis in mice with multiple targets against activated T lymphocytes.
Wu XF; Wu XX; Guo WJ; Luo Q; Gu YH; Shen Y; Tan RX; Sun Y; Xu Q
Toxicol Appl Pharmacol; 2012 Sep; 263(3):296-302. PubMed ID: 22789836
[TBL] [Abstract][Full Text] [Related]
2. The protective effect of the vagus nerve in a murine model of chronic relapsing colitis.
Ghia JE; Blennerhassett P; El-Sharkawy RT; Collins SM
Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G711-8. PubMed ID: 17673544
[TBL] [Abstract][Full Text] [Related]
3. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.
Loher F; Bauer C; Landauer N; Schmall K; Siegmund B; Lehr HA; Dauer M; Schoenharting M; Endres S; Eigler A
J Pharmacol Exp Ther; 2004 Feb; 308(2):583-90. PubMed ID: 14610233
[TBL] [Abstract][Full Text] [Related]
4. Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and induction of apoptosis.
Sun Y; Cai TT; Zhou XB; Xu Q
Int Immunopharmacol; 2009 Jul; 9(7-8):978-83. PubMed ID: 19375524
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria-dependent apoptosis of activated T lymphocytes induced by astin C, a plant cyclopeptide, for preventing murine experimental colitis.
Shen Y; Luo Q; Xu H; Gong F; Zhou X; Sun Y; Wu X; Liu W; Zeng G; Tan N; Xu Q
Biochem Pharmacol; 2011 Aug; 82(3):260-8. PubMed ID: 21569765
[TBL] [Abstract][Full Text] [Related]
6. A novel mTOR inhibitor is efficacious in a murine model of colitis.
Bhonde MR; Gupte RD; Dadarkar SD; Jadhav MG; Tannu AA; Bhatt P; Bhatia DR; Desai NK; Deore V; Yewalkar N; Vishwakarma RA; Sharma S; Kumar S; Dagia NM
Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1237-45. PubMed ID: 18927209
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of triptolide on interleukin-10 gene-deficient mice with colitis.
Wei X; Gong J; Zhu J; Niu L; Zhu W; Li N; Li J
Int Immunopharmacol; 2008 Dec; 8(13-14):1808-12. PubMed ID: 18804190
[TBL] [Abstract][Full Text] [Related]
8. Dietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines.
Yasui Y; Hosokawa M; Mikami N; Miyashita K; Tanaka T
Chem Biol Interact; 2011 Aug; 193(1):79-87. PubMed ID: 21621527
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
[TBL] [Abstract][Full Text] [Related]
10. T cell-associated CD18 but not CD62L, ICAM-1, or PSGL-1 is required for the induction of chronic colitis.
Ostanin DV; Furr KL; Pavlick KP; Gray L; Kevil CG; Shukla D; D'Souza D; Hoffman JM; Grisham MB
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1706-14. PubMed ID: 17332469
[TBL] [Abstract][Full Text] [Related]
11. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.
Mikami S; Nakase H; Yamamoto S; Takeda Y; Yoshino T; Kasahara K; Ueno S; Uza N; Oishi S; Fujii N; Nagasawa T; Chiba T
J Pharmacol Exp Ther; 2008 Nov; 327(2):383-92. PubMed ID: 18716065
[TBL] [Abstract][Full Text] [Related]
12. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.
Tamaki H; Nakamura H; Nishio A; Nakase H; Ueno S; Uza N; Kido M; Inoue S; Mikami S; Asada M; Kiriya K; Kitamura H; Ohashi S; Fukui T; Kawasaki K; Matsuura M; Ishii Y; Okazaki K; Yodoi J; Chiba T
Gastroenterology; 2006 Oct; 131(4):1110-21. PubMed ID: 17030181
[TBL] [Abstract][Full Text] [Related]
13. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
14. Beauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway.
Wu XF; Xu R; Ouyang ZJ; Qian C; Shen Y; Wu XD; Gu YH; Xu Q; Sun Y
PLoS One; 2013; 8(12):e83013. PubMed ID: 24340073
[TBL] [Abstract][Full Text] [Related]
15. 7-hydroxyfrullanolide, a sesquiterpene lactone, inhibits pro-inflammatory cytokine production from immune cells and is orally efficacious in animal models of inflammation.
Fonseca LC; Dadarkar SS; Lobo AS; Suthar AC; Chauhan VS; Chandrababu S; Sharma SD; Dagia NM; Padigaru M
Eur J Pharmacol; 2010 Oct; 644(1-3):220-9. PubMed ID: 20621086
[TBL] [Abstract][Full Text] [Related]
16. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
Houdeau E; Moriez R; Leveque M; Salvador-Cartier C; Waget A; Leng L; Bueno L; Bucala R; Fioramonti J
Gastroenterology; 2007 Mar; 132(3):982-93. PubMed ID: 17324399
[TBL] [Abstract][Full Text] [Related]
17. Aggravation of intestinal inflammation by depletion/deficiency of gammadelta T cells in different types of IBD animal models.
Kühl AA; Pawlowski NN; Grollich K; Loddenkemper C; Zeitz M; Hoffmann JC
J Leukoc Biol; 2007 Jan; 81(1):168-75. PubMed ID: 17041003
[TBL] [Abstract][Full Text] [Related]
18. Regulation of gut inflammation and th17 cell response by interleukin-21.
Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
[TBL] [Abstract][Full Text] [Related]
19. The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice.
Daniel C; Radeke HH; Sartory NA; Zahn N; Zuegel U; Steinmeyer A; Stein J
J Pharmacol Exp Ther; 2006 Nov; 319(2):622-31. PubMed ID: 16914561
[TBL] [Abstract][Full Text] [Related]
20. IL-15 protects intestinal epithelial cells.
Obermeier F; Hausmann M; Kellermeier S; Kiessling S; Strauch UG; Duitman E; Bulfone-Paus S; Herfarth H; Bock J; Dunger N; Stoeck M; Schölmerich J; Falk W; Rogler G
Eur J Immunol; 2006 Oct; 36(10):2691-9. PubMed ID: 16981178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
